Adma Biologics
$9.62
234
+$0.04+0.42% 19:59 Today
-$0.04-0.42%20:05After hours
Statistics
Day High
9.62
Day Low
9.39
52W High
20.46
52W Low
7.21
Volume
1,398,848
Avg. Volume
2,800,353
Mkt Cap
2.15B
P/E Ratio
13.35
Dividend Yield
-
Dividend
-
Upcoming
Earnings
11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.14
0.16
0.18
0.2
Expected EPS
0.196667
Actual EPS
N/A
Financials
28.8%Profit Margin
Profitable510.17MRevenue
146.93MNet Income
Analyst Ratings
19.00Average Price Target
The highest estimate is 21.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 67%
Hold 33%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ADMA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Takeda Pharmaceutical
TAK
Mkt Cap57.58B
Carlisle Companies
CSL
Mkt Cap14.16B
Grifols SA
GRFS
Mkt Cap5.23B
Biomarin Pharmaceutical
BMRN
Mkt Cap12.52B
Pfizer
PFE
Mkt Cap159.36B
GSK
GSK
Mkt Cap101.78B
Abbvie
ABBV
Mkt Cap451.46B
AMGEN
AMGN
Mkt Cap233.78B
Biogen
BIIB
Mkt Cap32.28B
Johnson & Johnson
JNJ
Mkt Cap645.95B
About
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
Show more...
CEO
Adam S. Grossman
Employees
647
Country
United States
ISIN
US0008991046
Listings
0 Comments
Share your thoughts
FAQ
What is Adma Biologics stock price today?▼
The current price of ADMA is $9.62 USD — it has increased by +0.42% in the past 24 hours. Watch Adma Biologics stock price performance more closely on the chart.
What is Adma Biologics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Adma Biologics stocks are traded under the ticker ADMA.
Is Adma Biologics stock price growing?▼
ADMA stock has risen by +3% compared to the previous week, the month change is a +7.97% rise, over the last year Adma Biologics has showed a -43.09% decrease.
What is Adma Biologics market cap?▼
Today Adma Biologics has the market capitalization of 2.15B
When is the next Adma Biologics earnings date?▼
Adma Biologics is going to release the next earnings report on November 11, 2026.
What were Adma Biologics earnings last quarter?▼
ADMA earnings for the last quarter are 0.16 USD per share, whereas the estimation was 0.16 USD resulting in a +0.98% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Adma Biologics revenue for the last year?▼
Adma Biologics revenue for the last year amounts to 510.17M USD.
What is Adma Biologics net income for the last year?▼
ADMA net income for the last year is 146.93M USD.
How many employees does Adma Biologics have?▼
As of September 04, 2026, the company has 647 employees.
In which sector is Adma Biologics located?▼
Adma Biologics operates in the Health & Wellness sector.
When did Adma Biologics complete a stock split?▼
Adma Biologics has not had any recent stock splits.
Where is Adma Biologics headquartered?▼
Adma Biologics is headquartered in RAMSEY, United States.